Answer
Yes, hepatitis B virus reactivation has been reported during post-marketing use of lenalidomide, including Grade 3–4 reactions, with frequency not known.
Sources for this answer
- Lenalidomide 2.5mg Hard CapsulesTeva UK Limited · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked